Part 1. Introduction 1.1 Market Definition 1.2 Key Benefit 1.3 Market Segment Part 2. Methodology 2.1 Primary 2.2 Secondary Part 3. Executive Summary Part 4. Market Overview 4.1 Introduction 4.2 Market Size and Forecast 4.3 Market Dynamics 4.3.1 Drivers 4.3.2 Restraints 4.4 Impact of COVID-19 Pandemic on Global Economy 4.5 Porter's Five Forces Analysis 4.5.1 Bargaining Power of Suppliers 4.5.2 Bargaining Power of Consumers 4.5.3 Threat of New Entrants 4.5.4 Threat of Substitute Products and Services 4.5.5 Degree of Competition Part 5. Global Market for Thiamine by Application 5.1 Market Overview 5.2 Animal Feed 5.2.1 Market Size and Forecast 5.3 Food & Beverages 5.3.1 Market Size and Forecast 5.4 Pharmaceuticals 5.4.1 Market Size and Forecast Part 6. Global Market for Thiamine by Geography 6.1 Overview 6.1.1 Market Size and Forecast 6.2 North America 6.2.1 Market Size and Forecast 6.2.2 North America: Thiamine Market by Country 6.2.2.1 United States 6.2.2.2 Canada 6.2.2.3 Mexico 6.3 Europe 6.3.1 Market Size and Forecast 6.3.2 Europe: Thiamine Market by Country 6.3.2.1 Germany 6.3.2.2 France 6.3.2.3 United Kingdom 6.3.2.4 Italy 6.3.2.5 Rest of The Europe 6.4 Asia-Pacific 6.4.1 Market Size and Forecast 6.4.2 Asia-Pacific: Thiamine Market by Country 6.4.2.1 China 6.4.2.2 India 6.4.2.3 Japan 6.4.2.4 South Korea 6.4.2.5 ASEAN Countries 6.5 Middle East and Africa (MEA) 6.5.1 Market Size and Forecast 6.5.2 MEA: Thiamine Market by Country 6.5.2.1 Saudi Arabia 6.5.2.2 South Africa 6.5.2.3 Turkey 6.6 South America 6.6.1 Market Size and Forecast 6.6.2 South America: Thiamine Market by Country 6.6.2.1 Brazil 6.6.2.2 Argentina 6.6.2.3 Rest of South America Part 7. Competitive Landscape 7.1 Market Share 7.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships Part 8. Key Competitor Profiles 8.1 Brother Enterprises Holding Co., Ltd. 8.2 DSM Nutritional Products AG 8.3 Huazhong Pharmaceutical Co., Ltd. 8.4 Jiangsu Jubang Pharmaceutical Co., Ltd. 8.5 Jiangxi Tianxin Pharmaceutical Co., Ltd. 8.6 Tianjin Zhongjin Pharmaceutical Co., Ltd. 8.7 Xinfa Pharmaceutical Co., Ltd. *LIST IS NOT EXHAUSTIVE Part 9. Patent Analysis 9.1 Patent Statistics 9.2 Regional Analysis 9.3 Trends Analysis DISCLAIMER ABOUT GEN CONSULTING COMPANY